
Latest news - Johnson & Johnson
A collection of stories that highlight the way Johnson & Johnson is making an impact in the lives of its consumers, and the latest press releases from the company.
Johnson & Johnson (JNJ) Latest Stock News & Headlines
Get the latest Johnson & Johnson (JNJ) stock news and headlines to help you in your trading and investing decisions.
Press Releases - Johnson & Johnson
2025年3月21日 · Explore all Johnson & Johnson published press releases by date and/or topic of news.
Johnson & Johnson Increases U.S. Investment to More than $55 …
2025年3月21日 · NEW BRUNSWICK, N.J.--(BUSINESS WIRE)-- Today, Johnson & Johnson (NYSE: JNJ) (the “Company”), healthcare’s leading, most comprehensive innovation powerhouse, announced manufacturing, research and development, and technology investments of more than $55 billion in the United States over the next four years. This represents a 25% increase in investment compared to the previous four years ...
Johnson & Johnson plans $55 billion in US ... - Associated Press News
6 天之前 · Johnson & Johnson says it will invest more than $55 billion within the United States over the next four years, including four new manufacturing plants. A number of companies have highlighted investments in the U.S. in recent months, a focus of Trump administration.
J&J (JNJ) Commits $55B to U.S. Manufacturing Expansion as …
2025年3月21日 · Johnson & Johnson (JNJ) announced its plans to invest over $55 billion over the next four years in the U.S. to strengthen its manufacturing, R&D, and technology capabilities. Notably, J&J has ...
J&J boosts US investments by 25% over 4 years amid looming …
6 天之前 · Johnson & Johnson has laid out plans to raise U.S. investments by 25% to more than $55 billion over the next four years, as a threat of drug import duties by the Trump administration compels ...
J&J buys Intra-Cellular in $14.6 billion deal ... - Associated Press News
2025年1月13日 · Johnson & Johnson will spend more than $14 billion to delve further into the treatment of central nervous system disorders by purchasing Intra-Cellular Therapies. The health care giant said Monday that it will pay $132 in cash for each share of Intra-Cellular. That represents a 39% premium to Intra-Cellular’s closing price of $94.87 on Friday.
News | Johnson & Johnson - Investors
2025年3月20日 · You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact us with any questions or search this site for more information.
Johnson & Johnson boosts US manufacturing as big pharma …
1 天前 · Dive Brief: Johnson & Johnson is planning a major U.S. expansion, announcing Friday it will spend $55 billion over the next four years on manufacturing, research and development and technology in its domestic market. The investments will support three advanced manufacturing facilities and expansion of other sites in its pharmaceutical and …